Hospital México reports that it has invested $446,000 in new equipment and chemicals to more quickly provide responses to biopsies.
The device, called an autostainer, is in the Servicio de Patología. The device will allow technicians to automate the staining and the immunohistochemistry process that identifies cancerous cells, said the Caja Costarricense de Seguro Social, which operates the public hospital.
Previously the staining was done manually and the job was tedious. Each patient donates nine samples of a typical biopsy evaluation. Each must be stained with chemicals and treated with antigens to assess the reaction. That way technicians and pathologists can identify cancerous tissue.
The investment by the Caja includes training and maintenance of the device.